Although TP53 mutation is reported to be related to the GI/HRD score across cancers in TCGA12,13, our results reveal for the first time that biallelic alterations, not monoallelic alteration of TP53 are associated with GI/HRD score. This evidence concerns the gene TP53 and cancer.